
Professor David Venables
Director
Professor David Venables has three decades of experience as a serial biotech entrepreneur having taken companies from creation through to acquisition or IPO, and taken products from development through to commercial launch.
He is currently Founding CEO of Laverock Therapeutics, Board member of Axol Bioscience, and mentor to a number of start-ups.
David has held CEO or Senior Executive roles in AskBio, Synpromics, Nightstar, Anatara Lifesciences, Ark Therapeutics, Valneva; he is Honorary Professor at Edinburgh University, and holds a PhD in Bioprocess Engineering from the University of Surrey.